1. M. Benetkiewicz, A. Idbaih, P. Y. Cousin, B. Boisselier, Y. Marie, E. Criniere, K. Hoang-Xuan, J. Y. Delattre, M. Sanson, and O. Delattre. NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas. PLoS ONE, 4(1):e4107, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Base Sequence, *Brain Neoplasms/genetics/metabolism, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, *Gene Rearrangement, Humans, Molecular Sequence Data, *Mutation, *Oligodendroglioma/genetics/metabolism, Oligonucleotide Array Sequence Analysis, Receptor, Notch2/*genetics/metabolism, *Translocation, Genetic.



2. B. Boisselier, Y. Marie, S. El Hallani, G. Kaloshi, A. Iershov, V. Kavsan, D. Psimaras, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis. J Neurooncol, 94(2):169-72, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW]



3. F. Ducray, E. Criniere, A. Idbaih, K. Mokhtari, Y. Marie, S. Paris, S. Navarro, F. Laigle-Donadey, C. Dehais, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. alpha-Internexin expression identifies 1p19q codeleted gliomas. Neurology, 72(2):156-61, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/diagnosis/*genetics, Chromosomes, Human, Pair 1/*genetics, Chromosomes, Human, Pair 19/*genetics, DNA Mutational Analysis, Disease Progression, Gene Deletion, Genes, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Glioma/diagnosis/*genetics, Humans, Intermediate Filament Proteins/*genetics, Mutation/genetics, Oligodendroglioma/diagnosis/genetics, Predictive Value of Tests, Prognosis.



4. S. El Hallani, B. Boisselier, Y. Marie, S. Paris, A. Idbaih, C. Carpentier, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 mutations but no CHEK2 *1100DelC variant in familial gliomas. Cancer Genet Cytogenet, 188(2):126-8, 2009. Note: LetterUnited States. [WWW] Keyword(s): Family, Female, Genetic Variation, Germ-Line Mutation, Glioma/*genetics, Humans, Male, *Mutation, Protein-Serine-Threonine Kinases/*genetics, *Sequence Deletion, Tumor Suppressor Protein p53/*genetics.



5. S. El Hallani, F. Ducray, A. Idbaih, Y. Marie, B. Boisselier, C. Colin, F. Laigle-Donadey, M. Rodero, O. Chinot, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology, 72(4):332-6, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Age of Onset, Aged, Aged, 80 and over, Codon/blood/*genetics, Female, Follow-Up Studies, Gene Frequency/genetics, Genetic Variation/genetics, Glioblastoma/blood/epidemiology/*genetics, Humans, Male, Middle Aged, Mutation/genetics, Polymorphism, Single Nucleotide/*genetics, Tumor Suppressor Protein p53/blood/*genetics, Young Adult.



6. S. Everhard, J. Tost, H. El Abdalaoui, E. Criniere, F. Busato, Y. Marie, I. G. Gut, M. Sanson, K. Mokhtari, F. Laigle-Donadey, K. Hoang-Xuan, J. Y. Delattre, and J. Thillet. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro Oncol, 11(4):348-56, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Brain Neoplasms/enzymology/*genetics/pathology, CpG Islands, *DNA Methylation, DNA Modification Methylases/*genetics/*metabolism, DNA Repair Enzymes/*genetics/*metabolism, *Gene Expression Regulation, Enzymologic, Genotype, Glioblastoma/enzymology/*genetics/pathology, Humans, Promoter Regions, Genetic/*genetics, Tumor Suppressor Proteins/*genetics/*metabolism.



7. A. Idbaih, J. Aimard, B. Boisselier, Y. Marie, S. Paris, E. Criniere, R. Carvalho Silva, F. Laigle-Donadey, A. Rousseau, K. Mokhtari, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol, 35(2):208-13, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Age of Onset, Brain Neoplasms/chemistry/*genetics, DNA Mutational Analysis, Female, Gene Expression, Glioblastoma/chemistry/*genetics, Humans, Male, Mutation, Missense, Protein Structure, Quaternary, Protein Structure, Tertiary, Receptor, Epidermal Growth Factor/chemistry/*genetics, Sex Characteristics.



8. A. Idbaih, E. Criniere, K. L. Ligon, O. Delattre, and J. Y. Delattre. Array-Based Genomics in Glioma Research. Brain Pathol, 2009. Note: Journal article. [WWW]



9. G. Kaloshi, R. Guillevin, N. Martin-Duverneuil, F. Laigle-Donadey, D. Psimaras, Y. Marie, K. Mokhtari, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri. Neurology, 73(6):445-9, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents/pharmacology/therapeutic use, Cell Movement/physiology, Cerebral Cortex/drug effects/*pathology, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*diagnosis/*drug therapy/mortality/pathology, Neuroglia/pathology, Predictive Value of Tests, Prognosis, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult.



10. A. Rousseau, A. Idbaih, F. Ducray, E. Criniere, M. Fevre-Montange, A. Jouvet, and J. Y. Delattre. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol, 2009. Note: Journal article. [WWW]



11. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J. Y. Delattre. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 27(25):4150-4, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms/enzymology/*genetics/mortality/pathology/therapy, Codon, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Disease-Free Survival, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glioma/enzymology/*genetics/mortality/pathology/therapy, Humans, Isocitrate Dehydrogenase/*genetics, Kaplan-Meiers Estimate, Male, Middle Aged, *Mutation, Neoplasm Staging, Promoter Regions, Genetic, Proportional Hazards Models, Risk Assessment, Time Factors, Treatment Outcome, Tumor Markers, Biological/*genetics, Tumor Suppressor Proteins/genetics, Young Adult.



12. S. Shete, F. J. Hosking, L. B. Robertson, S. E. Dobbins, M. Sanson, B. Malmer, M. Simon, Y. Marie, B. Boisselier, J. Y. Delattre, K. Hoang-Xuan, S. El Hallani, A. Idbaih, D. Zelenika, U. Andersson, R. Henriksson, A. T. Bergenheim, M. Feychting, S. Lonn, A. Ahlbom, J. Schramm, M. Linnebank, K. Hemminki, R. Kumar, S. J. Hepworth, A. Price, G. Armstrong, Y. Liu, X. Gu, R. Yu, C. Lau, M. Schoemaker, K. Muir, A. Swerdlow, M. Lathrop, M. Bondy, and R. S. Houlston. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet, 41(8):899-904, 2009. Note: 5R01 CA070917/CA/NCI NIH HHS/United States5R01 CA119215/CA/NCI NIH HHS/United StatesC1298/A8362/Cancer Research UK/United KingdomR01 CA119215/CA/NCI NIH HHS/United StatesWellcome Trust/United KingdomJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Alleles, *Genetic Predisposition to Disease, *Genome-Wide Association Study, Glioma/*genetics, Humans, Linkage Disequilibrium/genetics, Polymorphism, Single Nucleotide/genetics, Reproducibility of Results.



13. S. Taillibert, L. A. Vincent, B. Granger, Y. Marie, C. Carpentier, R. Guillevin, A. Bellanger, K. Mokhtari, A. Rousseau, D. Psimaras, C. Dehais, M. Sierra del Rio, Y. Meng, F. Laigle-Donadey, K. Hoang-Xuan, M. Sanson, and J. Y. Delattre. Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Neurology, 72(18):1601-6, 2009. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Aged, Angiogenesis Inhibitors/administration & dosage/adverse effects, Antibodies, Monoclonal/*administration & dosage/adverse effects, Antineoplastic Agents, Phytogenic/administration & dosage/adverse effects, Brain Neoplasms/*drug therapy/pathology/physiopathology, Camptothecin/administration & dosage/adverse effects/*analogs &, derivatives, Cerebral Hemorrhage/epidemiology, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/genetics, Genetic Screening, Humans, Male, Middle Aged, Neoplasm Recurrence, Local/*drug therapy/prevention & control, Oligodendroglioma/*drug therapy/pathology/physiopathology, Patient Compliance, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult.



14. A. Amiot, F. Joly, B. Messing, H. Sokol, A. Lavergne-Slove, J. Y. Delattre, and Y. Bouhnik. [Chronic intestinal pseudo-obstruction and anti-Hu syndrome: 13 years of follow-up without neoplasia]. Gastroenterol Clin Biol, 32(1 Pt. 1):51-5, 2008. Note: Case ReportsEnglish AbstractJournal ArticleFrance. [WWW] Keyword(s): Antibodies/analysis, Chronic Disease, Female, Follow-Up Studies, Ganglia, Autonomic/pathology, Hu Paraneoplastic Encephalomyelitis Antigens/*analysis, Humans, Intestinal Pseudo-Obstruction/*diagnosis/pathology, Middle Aged, Myenteric Plexus/pathology, Syndrome.



15. F. Ducray, A. Benouaich-Amiel, A. Idbaih, A. Rousseau, F. Laigle-Donadey, J. Y. Delattre, and M. Sanson. Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. J Neurooncol, 88(2):185-8, 2008. Note: Case ReportsJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Brain Neoplasms/complications/*drug therapy/genetics/pathology, Chromosome Deletion, Chromosomes, Human, X/genetics, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/*analogs & derivatives/therapeutic use, Female, Glioblastoma/complications/*drug therapy/genetics/pathology, Humans, Tomography, X-Ray Computed, Tumor Suppressor Proteins/genetics.



16. F. Ducray, A. Idbaih, A. de Reynies, I. Bieche, J. Thillet, K. Mokhtari, S. Lair, Y. Marie, S. Paris, M. Vidaud, K. Hoang-Xuan, O. Delattre, J. Y. Delattre, and M. Sanson. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer, 7:41, 2008. Note: Journal ArticleEngland. [WWW]



17. A. Idbaih, B. Boisselier, Y. Marie, M. Sanson, S. El Hallani, E. Criniere, M. Fourtassi, S. Paris, C. Carpentier, A. Rousseau, K. Mokhtari, C. Combadiere, F. Laigle-Donadey, K. Hoang-Xuan, and J. Y. Delattre. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Res, 1198:16-20, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Brain Neoplasms/*genetics/metabolism/physiopathology, Chromosomes, Human, Pair 1/genetics, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Humans, Male, Middle Aged, Oligodendroglioma/*genetics/metabolism/physiopathology, Phenotype, Polymorphism, Single Nucleotide/*genetics, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Retrospective Studies, Survival Rate, Tumor Suppressor Protein p53/*genetics.



18. A. Idbaih, R. Carvalho Silva, E. Criniere, Y. Marie, C. Carpentier, B. Boisselier, S. Taillibert, A. Rousseau, K. Mokhtari, F. Ducray, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Genomic changes in progression of low-grade gliomas. J Neurooncol, 90(2):133-40, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Chromosome Deletion, Chromosomes, Disease Progression, Female, Genome/*genetics, Glioma/*genetics/*metabolism, Humans, Male, Microsatellite Repeats, Middle Aged, Nucleic Acid Hybridization/methods.



19. A. Idbaih, E. Criniere, Y. Marie, A. Rousseau, K. Mokhtari, M. Kujas, Y. El Houfi, C. Carpentier, S. Paris, B. Boisselier, F. Laigle-Donadey, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro Oncol, 10(4):540-7, 2008. Note: Journal ArticleUnited States. [WWW]



20. A. Idbaih, M. Kouwenhoven, J. Jeuken, C. Carpentier, T. Gorlia, J. M. Kros, P. French, J. L. Teepen, O. Delattre, J. Y. Delattre, M. van den Bent, and K. Hoang-Xuan. Chromosome 1p loss evaluation in anaplastic oligodendrogliomas. Neuropathology, 28(4):440-3, 2008. Note: Case ReportsJournal ArticleResearch Support, Non-U.S. Gov'tAustraliaofficial journal of the Japanese Society of Neuropathology. [WWW] Keyword(s): Brain Neoplasms/*genetics, *Chromosome Deletion, Chromosomes, Artificial, Bacterial, Chromosomes, Human, Pair 1/*genetics, Humans, In Situ Hybridization, Fluorescence, Middle Aged, Nucleic Acid Hybridization/*methods, Oligodendroglioma/*genetics, Tumor Markers, Biological/genetics.



21. A. Idbaih, Y. Marie, C. Lucchesi, G. Pierron, E. Manie, V. Raynal, V. Mosseri, K. Hoang-Xuan, M. Kujas, I. Brito, K. Mokhtari, M. Sanson, E. Barillot, A. Aurias, J. Y. Delattre, and O. Delattre. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer, 122(8):1778-86, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Astrocytoma/genetics/pathology, Brain Neoplasms/classification/*genetics/*pathology, *Chromosome Deletion, Chromosomes, Artificial, Bacterial, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Chromosomes, Human, Pair 19, Chromosomes, Human, Pair 7, Chromosomes, Human, Pair 9, Disease-Free Survival, Female, Glioma/classification/*genetics/*pathology, Humans, Loss of Heterozygosity, Male, Middle Aged, Multivariate Analysis, Nucleic Acid Hybridization, Oligodendroglioma/genetics/pathology, Oligonucleotides, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Receptor, Epidermal Growth Factor/*genetics, Survival Analysis, World Health Organization.



22. A. Idbaih, S. Paris, B. Boisselier, Y. Marie, M. Sanson, J. Thillet, K. Hoang-Xuan, and J. Y. Delattre. Mutational analysis of Rac2 in gliomas. J Neurooncol, 87(3):365-6, 2008. Note: LetterResearch Support, Non-U.S. Gov'tNetherlands. [WWW]



23. G. Kaloshi, S. Everhard, F. Laigle-Donadey, Y. Marie, S. Navarro, K. Mokhtari, A. Idbaih, F. Ducray, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology, 70(8):590-5, 2008. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Chromosome Mapping, *Chromosomes, Human, Pair 19, Cohort Studies, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/therapeutic use, Disease-Free Survival, Female, Genetic Markers/physiology, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/*genetics, O(6)-Methylguanine-DNA Methyltransferase/*metabolism, Prognosis, Retrospective Studies, Tumor Markers, Biological.



24. Y. Meng, M. Kujas, Y. Marie, S. Paris, J. Thillet, J. Y. Delattre, and A. F. Carpentier. Expression of TLR9 within human glioblastoma. J Neurooncol, 88(1):19-25, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Animals, Brain Neoplasms/*genetics/metabolism/pathology, Female, Fluorescent Antibody Technique, Glioblastoma/*genetics/metabolism/pathology, Humans, Immunohistochemistry, Karnofsky Performance Status, Lymphocytes/pathology, Male, Mice, Mice, Nude, Middle Aged, Neoplasm Transplantation, Neurosurgical Procedures, RNA, Messenger/biosynthesis/genetics, Reverse Transcriptase Polymerase Chain Reaction, Survival, Toll-Like Receptor 9/*biosynthesis/*genetics.



25. C. Carpentier, J. Lejeune, F. Gros, S. Everhard, Y. Marie, G. Kaloshi, F. Laigle-Donadey, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol, 84:249-253, 2007. Note: Journal article. [WWW]



26. E. Criniere, G. Kaloshi, F. Laigle-Donadey, J. Lejeune, N. Auger, A. Benouaich-Amiel, S. Everhard, K. Mokhtari, M. Polivka, J. Y. Delattre, K. Hoang-Xuan, J. Thillet, and M. Sanson. MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol, 83:173-179, 2007. Note: Journal article. [WWW]



27. S. El Hallani, Y. Marie, A. Idbaih, M. Rodero, B. Boisselier, F. Laigle-Donadey, F. Ducray, J. Y. Delattre, and M. Sanson. No association of MDM2 SNP309 with risk of glioblastoma and prognosis. J Neurooncol, 85(3):241-4, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality/pathology, Case-Control Studies, Female, Gene Expression Regulation, Neoplastic/genetics, Genetic Predisposition to Disease, Glioblastoma/*genetics/mortality/pathology, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Reference Values, Risk Factors, Survival Analysis, Tumor Markers, Biological/*genetics.



28. A. Idbaih, B. Boisselier, M. Sanson, E. Criniere, S. Liva, Y. Marie, C. Carpentier, S. Paris, F. Laigle-Donadey, K. Mokhtari, M. Kujas, K. Hoang-Xuan, O. Delattre, and J. Y. Delattre. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas. Cancer Genet Cytogenet, 176(2):121-126, 2007. Note: Journal article. [WWW]



29. A. Idbaih, M. Kouwenhoven, J. Jeuken, A. Carpentier, T. Gorlia, M. Kros, P. French, O. Delattre, J. Y. Delattre, M. J. Van den Bent, and K. Hoang-Xuan. ``True and false''1p/19q codeletions in anaplastic oligodendrogial tumors. Neuropathology, pp sous-presse, 2007.



30. G. Kaloshi, A. Benouaich-Amiel, F. Diakite, S. Taillibert, J. Lejeune, F. Laigle-Donadey, M. A. Renard, W. Iraqi, A. Idbaih, S. Paris, L. Capelle, H. Duffau, P. Cornu, J. M. Simon, K. Mokhtari, M. Polivka, A. Omuro, A. Carpentier, M. Sanson, J. Y. Delattre, and K. Hoang-Xuan. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology, 68(21):1831-6, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/*drug therapy/*genetics/physiopathology, *Chromosome Deletion, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, Dacarbazine/administration & dosage/*analogs & derivatives, Drug Resistance, Neoplasm/*genetics, Female, Gene Expression Regulation, Neoplastic/drug effects/genetics, Genetic Screening, Genotype, Glioma/*drug therapy/*genetics/physiopathology, Humans, Loss of Heterozygosity/genetics, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy/genetics, Retrospective Studies, Survival Rate, Treatment Outcome.



31. G. Kaloshi, K. Mokhtari, C. Carpentier, S. Taillibert, J. Lejeune, Y. Marie, J. Y. Delattre, R. Godbout, and M. Sanson. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status. J Neurooncol, 84:215-8, 2007. Note: Journal article. [WWW]



32. F. Keime-Guibert, O. Chinot, L. Taillandier, S. Cartalat-Carel, M. Frenay, G. Kantor, J. S. Guillamo, E. Jadaud, P. Colin, P. Y. Bondiau, P. Menei, H. Loiseau, V. Bernier, J. Honnorat, M. Barrie, K. Mokhtari, J. J. Mazeron, A. Bissery, and J. Y. Delattre. Radiotherapy for glioblastoma in the elderly. N Engl J Med, 356(15):1527-35, 2007. Note: Association of French-Speaking Neuro-OncologistsComparative StudyJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, Aged, 80 and over, Astrocytoma/mortality/radiotherapy/therapy, Brain Neoplasms/mortality/*radiotherapy/therapy, Cognition/radiation effects, Female, Glioblastoma/mortality/*radiotherapy/therapy, Humans, Male, Proportional Hazards Models, Quality of Life, Radiotherapy Dosage, Survival Analysis.



33. D. Ricard, G. Kaloshi, A. Amiel-Benouaich, J. Lejeune, Y. Marie, E. Mandonnet, M. Kujas, K. Mokhtari, S. Taillibert, F. Laigle-Donadey, A. F. Carpentier, A. Omuro, L. Capelle, H. Duffau, P. Cornu, R. Guillevin, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol, 61(5):484-90, 2007. Note: Journal ArticleUnited States. [WWW]



34. E. Vauleon, N. Auger, A. Benouaich-Amiel, F. Laigle-Donadey, G. Kaloshi, J. Lejeune, J. Y. Delattre, J. Thillet, and M. Sanson. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet, 172(1):33-7, 2007. Note: Journal ArticleUnited States. [WWW]



35. C. Carpentier, F. Laigle-Donadey, Y. Marie, N. Auger, A. Benouaich-Amiel, J. Lejeune, G. Kaloshi, J. Y. Delattre, J. Thillet, and M. Sanson. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma. Neurology, 67(5):872-4, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Alleles, Chi-Square Distribution, Female, Follow-Up Studies, Gene Frequency, Glioblastoma/*genetics, Humans, Male, Middle Aged, Odds Ratio, *Polymorphism, Genetic, Promoter Regions (Genetics)/*genetics, Prospective Studies, RNA, Messenger/metabolism, Receptor, Epidermal Growth Factor/*genetics, Reverse Transcriptase Polymerase Chain Reaction/methods, Risk Factors, Sp1 Transcription Factor/*metabolism, Survival Analysis.



36. X. Decleves, A. Amiel, J. Y. Delattre, and J. M. Scherrmann. Role of ABC transporters in the chemoresistance of human gliomas. Curr Cancer Drug Targets, 6(5):433-45, 2006. Note: Journal ArticleReviewNetherlands. [WWW] Keyword(s): ATP-Binding Cassette Transporters/*physiology, Animals, Brain Neoplasms/*drug therapy/epidemiology/pathology, *Drug Resistance, Neoplasm, Glioma/*drug therapy/epidemiology/pathology, Humans.



37. C. Dehais, F. Laigle-Donadey, Y. Marie, M. Kujas, J. Lejeune, A. Benouaich-Amiel, M. Pedretti, M. Polivka, K. H. Xuan, J. Thillet, J. Y. Delattre, and M. Sanson. Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Cancer, 107(8):1891-7, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Chromosomes, Human, Pair 9, Disease-Free Survival, Female, Glioma/*genetics/mortality, Humans, Loss of Heterozygosity, Male, Middle Aged, Molecular Diagnostic Techniques, Prognosis, Receptor, Epidermal Growth Factor/genetics, Survival Analysis, Tumor Suppressor Protein p53/metabolism.



38. S. Everhard, G. Kaloshi, E. Criniere, A. Benouaich-Amiel, J. Lejeune, Y. Marie, M. Sanson, M. Kujas, K. Mokhtari, K. Hoang-Xuan, J. Y. Delattre, and J. Thillet. MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann Neurol, 60(6):740-3, 2006. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/pharmacology/therapeutic use, Brain Neoplasms/diagnosis/*drug therapy/genetics, DNA Methylation/*drug effects, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/pharmacology/therapeutic use, Disease Progression, Female, Genetic Markers/drug effects/genetics, Glioma/diagnosis/*drug therapy/genetics, Humans, Male, Middle Aged, Neoadjuvant Therapy, Predictive Value of Tests, Prognosis, Promoter Regions (Genetics)/*drug effects/genetics, Survival Rate, Tumor Markers, Biological/*genetics, Tumor Suppressor Protein p14ARF/*genetics.



39. C. Houillier, J. Lejeune, A. Benouaich-Amiel, F. Laigle-Donadey, E. Criniere, K. Mokhtari, J. Thillet, J. Y. Delattre, K. Hoang-Xuan, and M. Sanson. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer, 106(10):2218-23, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Base Sequence, Brain Neoplasms/*genetics/*mortality/pathology, Disease Progression, Female, Gene Expression Regulation, Neoplastic, Genes, erbB-1/*genetics, Genetic Markers, Glioblastoma/*genetics/*mortality/pathology, Humans, Male, Middle Aged, Molecular Sequence Data, Multivariate Analysis, Neoplasm Staging, Polymerase Chain Reaction, Probability, Prognosis, Proportional Hazards Models, Proto-Oncogene Proteins c-mdm2/*genetics, Registries, Retrospective Studies, Risk Assessment, Sensitivity and Specificity, Survival Analysis.



40. F. Laigle-Donadey and J. Y. Delattre. Glioma in the elderly. Curr Opin Oncol, 18(6):644-7, 2006. Note: Journal ArticleUnited States. [WWW]



41. A. M. Omuro, C. C. Leite, K. Mokhtari, and J. Y. Delattre. Pitfalls in the diagnosis of brain tumours. Lancet Neurol, 5(11):937-48, 2006. Note: Journal ArticleReviewEngland. [WWW] Keyword(s): Brain Diseases/diagnosis, Brain Neoplasms/classification/*diagnosis, Diagnosis, Differential, Diagnostic Imaging/*methods/*trends, Humans.



42. L. Aguirre-Cruz, J. L. Charuel, A. F. Carpentier, B. Benyahia, J. Y. Delattre, and L. Musset. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J Neurooncol, 71(1):39-41, 2005. Note: Clinical TrialComparative StudyJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antibodies, Antinuclear/*immunology, Autoantibodies/*immunology, Breast Neoplasms/immunology, Carcinoma, Small Cell/immunology, DNA-Binding Proteins/*immunology, Female, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lung Neoplasms/immunology, Male, Middle Aged, Neoplasm Proteins/*immunology, Neoplasms/*immunology, Nerve Tissue Proteins/*immunology, Neurons/immunology, Ovarian Neoplasms/immunology, Paraneoplastic Syndromes, Nervous System/*immunology, Prostatic Neoplasms/immunology, RNA-Binding Proteins/*immunology, Urologic Neoplasms/immunology.



43. J. Hildebrand, C. Lecaille, J. Perennes, and J. Y. Delattre. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology, 65(2):212-5, 2005. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Anticonvulsants/therapeutic use, Antineoplastic Agents/therapeutic use, Brain/drug effects/pathology/*physiopathology, Causality, Cerebral Cortex/drug effects/pathology/physiopathology, Cohort Studies, Comorbidity, Disease Progression, Drug Combinations, Drug Resistance/physiology, Epilepsy/drug therapy/*epidemiology/physiopathology, Female, Follow-Up Studies, Glioma/*epidemiology/pathology/therapy, Humans, Male, Middle Aged, Radiotherapy/statistics & numerical data, Supratentorial Neoplasms/*epidemiology/pathology/therapy, Treatment Outcome.



44. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, M. Kujas, K. Mokhtari, M. Sanson, J. Lejeune, A. Aurias, O. Delattre, and J. Y. Delattre. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol, 58(3):483-7, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/classification/*genetics, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Female, Gene Expression Profiling, Glioma/classification/*genetics, Humans, Loss of Heterozygosity, Male, Middle Aged.



45. M. Kujas, J. Lejeune, A. Benouaich-Amiel, E. Criniere, F. Laigle-Donadey, Y. Marie, K. Mokhtari, M. Polivka, M. Bernier, F. Chretien, A. Couvelard, L. Capelle, H. Duffau, P. Cornu, P. Broet, J. Thillet, A. F. Carpentier, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol, 58(2):322-6, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain Neoplasms/*genetics/pathology, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Female, Glioma/*genetics/pathology, Humans, Immunohistochemistry/methods, *Loss of Heterozygosity, Male, Middle Aged, Molecular Biology/methods.



46. F. Laigle-Donadey, S. Taillibert, N. Martin-Duverneuil, J. Hildebrand, and J. Y. Delattre. Skull-base metastases. J Neurooncol, 75(1):63-9, 2005. Note: Journal ArticleReviewNetherlands. [WWW] Keyword(s): Humans, Magnetic Resonance Imaging, Skull Base Neoplasms/mortality/*secondary/therapy.



47. F. Laigle-Donadey, S. Taillibert, K. Mokhtari, J. Hildebrand, and J. Y. Delattre. Dural metastases. J Neurooncol, 75(1):57-61, 2005. Note: Journal ArticleReviewNetherlands. [WWW] Keyword(s): Dura Mater/*pathology, Hematoma, Subdural/diagnosis/mortality, Humans, Meningioma/diagnosis/mortality/*secondary.



48. Y. Marie, A. F. Carpentier, A. M. Omuro, M. Sanson, J. Thillet, K. Hoang-Xuan, and J. Y. Delattre. EGFR tyrosine kinase domain mutations in human gliomas. Neurology, 64(8):1444-5, 2005. Note: Journal ArticleUnited States. [WWW] Keyword(s): Astrocytoma/drug therapy/enzymology/genetics, Brain Neoplasms/drug therapy/*enzymology/*genetics, Carcinoma/drug therapy/enzymology/genetics, DNA Mutational Analysis, Drug Resistance, Neoplasm/genetics, Genetic Screening, Glioblastoma/drug therapy/enzymology/genetics, Glioma/drug therapy/*enzymology/*genetics, Humans, Lung Neoplasms/drug therapy/enzymology/genetics, Mutation/*genetics, Oligodendroglioma/drug therapy/enzymology/genetics, Protein Kinase Inhibitors/pharmacology/therapeutic use, Protein Structure, Tertiary/genetics, Quinazolines/pharmacology/therapeutic use, Receptor, Epidermal Growth Factor/*genetics.



49. Y. Meng, A. F. Carpentier, L. Chen, G. Boisserie, J. M. Simon, J. J. Mazeron, and J. Y. Delattre. Successful combination of local CpG-ODN and radiotherapy in malignant glioma. Int J Cancer, 116(6):992-7, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Cell Division/drug effects/radiation effects, Cell Line, Tumor, Combined Modality Therapy, Dinucleoside Phosphates/*therapeutic use, Disease Models, Animal, Gene Therapy/methods, Glioma/*drug therapy/genetics/*radiotherapy, Humans, Oligodeoxyribonucleotides/*therapeutic use, Rats, Rats, Inbred F344.



50. K. Mokhtari, S. Paris, L. Aguirre-Cruz, N. Privat, E. Criniere, Y. Marie, J. J. Hauw, M. Kujas, D. Rowitch, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol, 31(1):62-9, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/*classification/metabolism/pathology, Chromosomes, Human, Pair 1, Glial Fibrillary Acidic Protein/*metabolism, Glioma/*classification/metabolism/pathology, Humans, Immunohistochemistry, Loss of Heterozygosity, Nerve Tissue Proteins/*metabolism, Tumor Suppressor Protein p53/*metabolism.



51. G. Noel, M. A. Bollet, S. Noel, L. Feuvret, G. Boisserie, B. Tep, J. Y. Delattre, F. Baillet, C. Ambroise Valery, P. Cornu, and J. J. Mazeron. Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys, 63(5):1555-61, 2005. Note: Evaluation StudiesJournal ArticleUnited States. [WWW] Keyword(s): Aged, Aged, 80 and over, Brain Neoplasms/mortality/*secondary/*surgery, Epidemiologic Methods, Female, Humans, Male, Prognosis, Radiosurgery/*methods/standards, Radiotherapy Dosage.



52. S. Taillibert and J. Y. Delattre. Palliative care in patients with brain metastases. Curr Opin Oncol, 17(6):588-92, 2005. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Adrenal Cortex Hormones/adverse effects, Anticoagulants/adverse effects, Antineoplastic Agents/adverse effects, Brain Edema/prevention & control, Brain Neoplasms/*secondary/*therapy, Epilepsy/prevention & control, Humans, Pain/therapy, *Palliative Care/methods, Radiotherapy/adverse effects, Venous Thrombosis/prevention & control.



53. S. Taillibert, F. Laigle-Donadey, C. Chodkiewicz, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Leptomeningeal metastases from solid malignancy: a review. J Neurooncol, 75(1):85-99, 2005. Note: Journal ArticleReviewNetherlands. [WWW] Keyword(s): Breast Neoplasms/*pathology, Humans, Lung Neoplasms/*pathology, Meningeal Neoplasms/physiopathology/*secondary/therapy, Practice Guidelines.



54. L. Aguirre-Cruz, K. Mokhtari, K. Hoang-Xuan, Y. Marie, E. Criniere, S. Taillibert, M. Lopes, J. Y. Delattre, and M. Sanson. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors. J Neurooncol, 67(3):265-71, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Astrocytes/metabolism, Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/genetics/*metabolism/pathology, DNA Probes, DNA-Binding Proteins/genetics/*metabolism, Helix-Loop-Helix Motifs, Humans, In Situ Hybridization, Nerve Tissue Proteins/genetics/*metabolism, Neurons/metabolism, Oligodendroglia/metabolism.



55. B. Benyahia, S. Huguet, X. Decleves, K. Mokhtari, E. Criniere, J. F. Bernaudin, J. M. Scherrmann, and J. Y. Delattre. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol, 66(1-2):65-70, 2004. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Antineoplastic Agents, Phytogenic/*pharmacology, Brain Neoplasms/*metabolism/pathology/physiopathology, Cell Death/drug effects, Cell Line, Tumor, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm/*drug effects, Drug Synergism, Etoposide/*pharmacology, Female, Glioma/*metabolism/pathology/physiopathology, Humans, Indomethacin/administration & dosage/*pharmacology, Male, Middle Aged, Osmolar Concentration, P-Glycoprotein/*metabolism, Vincristine/*pharmacology.



56. C. Dichamp, S. Taillibert, L. Aguirre-Cruz, J. Lejeune, Y. Marie, M. Kujas, J. Y. Delattre, K. Hoang-Xuan, and M. Sanson. Loss of 14q chromosome in oligodendroglial and astrocytic tumors. J Neurooncol, 67(3):281-5, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Astrocytoma/*genetics/pathology, Brain Neoplasms/*genetics/pathology, Chromosomes, Human, Pair 14/*genetics, DNA, Neoplasm/genetics, Genes, erbB-1/genetics, Genes, p16/physiology, Genes, p53/genetics, Humans, *Loss of Heterozygosity, Microsatellite Repeats, Neoplasm Staging, Oligodendroglioma/*genetics/pathology, Phosphoric Monoester Hydrolases/genetics, Survival Rate.



57. F. Graus, J. Y. Delattre, J. C. Antoine, J. Dalmau, B. Giometto, W. Grisold, J. Honnorat, P. S. Smitt, Ch Vedeler, J. J. Verschuuren, A. Vincent, and R. Voltz. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 75(8):1135-40, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Antibodies/analysis, Diagnosis, Differential, Humans, Immunologic Tests, International Cooperation, Neoplasms/*complications, Neurology/*standards, Paraneoplastic Syndromes, Nervous System/*diagnosis, *Practice Guidelines, Reference Values.



58. K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Criniere, Y. Marie, K. Mokhtari, A. F. Carpentier, F. Laigle, J. M. Simon, P. Cornu, P. Broet, M. Sanson, and J. Y. Delattre. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol, 22(15):3133-8, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Astrocytoma/*drug therapy/*genetics, Brain Neoplasms/*drug therapy/*genetics, *Chromosome Deletion, Chromosomes, Human, Pair 1/*genetics, Dacarbazine/*analogs & derivatives/*therapeutic use, Female, Humans, Loss of Heterozygosity, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*drug therapy/*genetics.



59. F. Laigle-Donadey, N. Martin-Duverneuil, J. Lejeune, E. Criniere, L. Capelle, H. Duffau, P. Cornu, P. Broet, M. Kujas, K. Mokhtari, A. Carpentier, M. Sanson, K. Hoang-Xuan, J. Thillet, and J. Y. Delattre. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology, 63(12):2360-2, 2004. Note: Comparative StudyJournal ArticleReviewUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*genetics/pathology/*radiography, Cerebral Cortex/pathology/radiography, Chromosomes, Human, Pair 1/*genetics, Female, Humans, *Loss of Heterozygosity, Male, Microsatellite Repeats, Middle Aged, Oligodendroglioma/*genetics/pathology/*radiography, Retrospective Studies, Supratentorial Neoplasms/genetics/pathology/radiography.



60. C. Lefevre-Houillier, J. C. Willer, J. Y. Delattre, and N. Martin-Duverneuil. [Post-irradiation neuromyotonia of the masseter muscle]. Rev Neurol (Paris), 160(11):1075-7, 2004. Note: Case ReportsEnglish AbstractJournal ArticleReviewFrance. [WWW] Keyword(s): Aged, Humans, Isaacs Syndrome/*etiology, Male, *Masseter Muscle, Radiation Injuries/*etiology.



61. P. Leuraud, E. Dezamis, L. Aguirre-Cruz, S. Taillibert, J. Lejeune, E. Robin, K. Mokhtari, A. L. Boch, P. Cornu, J. Y. Delattre, and M. Sanson. Prognostic value of allelic losses and telomerase activity in meningiomas. J Neurosurg, 100(2):303-9, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Chromosome Mapping, Disease Progression, Female, Humans, Loss of Heterozygosity/*genetics, Male, Meningeal Neoplasms/*genetics, Meningioma/*genetics, Middle Aged, Neoplasm Recurrence, Local/*genetics, Predictive Value of Tests, Prognosis, Telomerase/*genetics/physiology.



62. P. Leuraud, L. Taillandier, J. Medioni, L. Aguirre-Cruz, E. Criniere, Y. Marie, M. Kujas, J. L. Golmard, A. Duprez, J. Y. Delattre, M. Sanson, and M. F. Poupon. Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations. Cancer Res, 64(13):4648-53, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Antineoplastic Agents, Alkylating/*pharmacology, Carboplatin/pharmacology, Carmustine/pharmacology, *Chromosome Aberrations, Dacarbazine/*analogs & derivatives/pharmacology, Glioblastoma/*drug therapy/*genetics/pathology, Humans, Ifosfamide/pharmacology, Loss of Heterozygosity, Mice, Mice, Nude, Mutation, Oligodendroglioma/*drug therapy/*genetics/pathology, Xenograft Model Antitumor Assays.



63. A. Llado, P. Mannucci, A. F. Carpentier, S. Paris, Y. Blanco, A. Saiz, J. Y. Delattre, and F. Graus. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology, 63(10):1947-9, 2004. Note: Evaluation StudiesJournal ArticleResearch Support, Non-U.S. Gov'tReviewUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Autoantibodies/*blood/immunology, Autoantigens/*immunology, Carcinoid Tumor/complications/immunology/therapy, Carcinoma, Small Cell/complications/immunology/therapy, Disease Progression, Female, Follow-Up Studies, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lung Neoplasms/complications/immunology/therapy, Male, Middle Aged, Nerve Tissue Proteins/*immunology, Paraneoplastic Syndromes, Nervous System/blood/*immunology, Predictive Value of Tests, RNA-Binding Proteins/*immunology, Retrospective Studies, Treatment Outcome.



64. G. Noel, C. N. Ben Ammar, L. Feuvret, C. A. Valery, P. Cornu, G. Boisserie, J. M. Simon, D. Hasboun, B. Tep, J. Y. Delattre, M. Sanson, F. Baillet, and J. J. Mazeron. [Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas]. Rev Neurol (Paris), 160(5 Pt 1):539-45, 2004. Note: English AbstractJournal ArticleFrance. [WWW] Keyword(s): Brain Neoplasms/pathology/*surgery, Female, Follow-Up Studies, Glioma/pathology/*surgery, Humans, Karnofsky Performance Status, Male, Middle Aged, Necrosis, Neoplasm Recurrence, Local, Prognosis, Radiation Dosage, *Radiosurgery/adverse effects, *Salvage Therapy, Survival Analysis.



65. G. Noel, C. A. Valery, G. Boisserie, P. Cornu, D. Hasboun, J. Marc Simon, B. Tep, D. Ledu, J. Y. Delattre, C. Marsault, F. Baillet, and J. J. Mazeron. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol, 22(1):25-31, 2004. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*secondary/*surgery, Carcinoma, Renal Cell/*secondary/*surgery, Disease-Free Survival, Female, Humans, Kidney Neoplasms/*pathology, Male, Middle Aged, Prognosis, *Radiosurgery/adverse effects, Radiotherapy Dosage, Treatment Outcome.



66. M. Sanson, S. Cartalat-Carel, S. Taillibert, M. Napolitano, L. Djafari, J. Cougnard, H. Gervais, F. Laigle, A. Carpentier, K. Mokhtari, L. Taillandier, O. Chinot, H. Duffau, J. Honnorat, K. Hoang-Xuan, and J. Y. Delattre. Initial chemotherapy in gliomatosis cerebri. Neurology, 63(2):270-5, 2004. Note: ANOCEF groupClinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/adverse effects/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration &, dosage/adverse effects/*therapeutic use, Astrocytoma/drug therapy/radiotherapy, Brain Neoplasms/*drug therapy/pathology/radiotherapy, Combined Modality Therapy, Cranial Irradiation, Dacarbazine/adverse effects/*analogs & derivatives/*therapeutic use, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Female, Hematologic Diseases/chemically induced, Humans, Karnofsky Performance Status, Lomustine/administration & dosage/adverse effects, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/pathology/radiotherapy, Oligodendroglioma/drug therapy/radiotherapy, Procarbazine/administration & dosage/adverse effects, Survival Analysis, Treatment Outcome, Vincristine/administration & dosage/adverse effects.



67. O. Trouillard, L. Aguirre-Cruz, K. Hoang-Xuan, Y. Marie, J. Y. Delattre, and M. Sanson. Parental 19q loss and PEG3 expression in oligodendrogliomas. Cancer Genet Cytogenet, 151(2):182-3, 2004. Note: LetterResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/*genetics, *Chromosome Deletion, *Chromosomes, Human, Pair 19, *Genomic Imprinting, Humans, Oligodendroglioma/*genetics, *Protein Kinases, Proteins/*genetics, *Transcription Factors.



68. A. Behin, K. Hoang-Xuan, A. F. Carpentier, and J. Y. Delattre. Primary brain tumours in adults. Lancet, 361(9354):323-31, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewEngland. [WWW] Keyword(s): Adult, *Brain Neoplasms/classification/diagnosis/genetics/physiopathology, Combined Modality Therapy, *Glioma/classification/diagnosis/genetics/physiopathology, Humans, Magnetic Resonance Imaging, Molecular Biology.



69. B. Benyahia, Z. Amoura, A. Rousseau, C. Le Clanche, A. Carpentier, J. C. Piette, and J. Y. Delattre. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases. J Neurooncol, 62(3):349-51, 2003. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Antigens, Neoplasm/immunology, Autoantibodies/*blood, Autoantigens, DNA-Binding Proteins/immunology, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lupus Erythematosus, Systemic/*immunology, Neoplasm Proteins/immunology, Nerve Tissue Proteins/*immunology, Neurons/*immunology, Paraneoplastic Syndromes/*immunology, RNA-Binding Proteins/*immunology, Recombinant Proteins/*immunology, Sjogren's Syndrome/*immunology.



70. B. Benyahia, A. F. Carpentier, and J. Y. Delattre. [Antineuron antibodies and paraneoplastic neurological syndromes]. Rev Neurol (Paris), 159(4):463-5, 2003. Note: Journal ArticleReviewFrance. [WWW] Keyword(s): Animals, Antibody Specificity, Autoantibodies/blood/*immunology, Autoantigens/immunology, Autoimmune Diseases/*immunology, Blotting, Western, Fluorescent Antibody Technique, Indirect, Humans, Nerve Tissue Proteins/immunology, Nervous System Diseases/*immunology, Neurons/*immunology, Paraneoplastic Syndromes/*immunology, Rats.



71. A. F. Carpentier, G. Auf, and J. Y. Delattre. CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma. Front Biosci, 8:e115-27, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewUnited Statesa journal and virtual library. [WWW] Keyword(s): Adjuvants, Immunologic/*therapeutic use, Animals, Central Nervous System Neoplasms/immunology/*therapy, CpG Islands/*immunology, Glioma/immunology/*therapy, Humans, Immunotherapy, Active/*methods, Oligodeoxyribonucleotides/*therapeutic use.



72. K. Hoang-Xuan, L. Taillandier, O. Chinot, P. Soubeyran, U. Bogdhan, J. Hildebrand, M. Frenay, N. De Beule, J. Y. Delattre, and B. Baron. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol, 21(14):2726-31, 2003. Note: European Organization for Research and Treatment of Cancer Brain Tumor GroupClinical TrialClinical Trial, Phase IIComparative StudyJournal ArticleMulticenter StudyUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Age Factors, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/*administration &, dosage/adverse effects, Belgium, Biopsy, Needle, Central Nervous System Neoplasms/*drug therapy/mortality/*pathology, Cytarabine/administration & dosage/adverse effects, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Infusions, Intravenous, Injections, Spinal, Lomustine/administration & dosage/adverse effects, Lymphoma/*drug therapy/mortality/*pathology, Male, Methotrexate/administration & dosage/adverse effects, Methylprednisolone/administration & dosage/adverse effects, Middle Aged, Multivariate Analysis, Neoplasm Staging, Probability, Procarbazine/administration & dosage/adverse effects, Research, Risk Assessment, Survival Analysis, Treatment Outcome.



73. P. Leuraud, L. Aguirre-Cruz, K. Hoang-Xuan, E. Criniere, M. L. Tanguy, J. L. Golmard, M. Kujas, J. Y. Delattre, and M. Sanson. Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1. Neurology, 60(11):1820-2, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Chromosome Mapping, *Chromosomes, Human, Pair 10, Glioma/enzymology/*genetics, Humans, *Loss of Heterozygosity, Telomerase/*metabolism.



74. P. Leuraud, L. Taillandier, L. Aguirre-Cruz, J. Medioni, E. Criniere, Y. Marie, A. M. Dutrillaux, M. Kujas, A. Duprez, J. Y. Delattre, M. F. Poupon, and M. Sanson. Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. Br J Cancer, 89(12):2327-32, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Adult, Aged, Animals, Cell Division/*genetics, Central Nervous System Neoplasms/*genetics/*pathology, Female, Genes, Tumor Suppressor/physiology, Genes, erbB-1/genetics, Genes, p53/genetics, Glioma/*genetics/*pathology, Humans, Loss of Heterozygosity/genetics, Male, Mice, Mice, Nude, Middle Aged, *Models, Animal, Mutation/*genetics, Neoplasm Transplantation, PTEN Phosphohydrolase, Phosphoric Monoester Hydrolases/genetics, Proto-Oncogenes/genetics, Telomerase/genetics, Tumor Suppressor Proteins/genetics.



75. E. Louis, C. Cret, J. Poirier, P. Cornu, N. Martin-Duverneuil, J. Y. Delattre, and M. Sanson. Intra-cerebral schwannoma simulating glioma. J Neurooncol, 64(3):279-82, 2003. Note: Case ReportsJournal ArticleNetherlands. [WWW] Keyword(s): Biopsy, Brain Neoplasms/*pathology/radiotherapy/surgery, Diagnosis, Differential, Female, Frontal Lobe/pathology/radiation effects/surgery, Glioma/*pathology/radiotherapy/surgery, Humans, Magnetic Resonance Imaging, Middle Aged, Neurilemmoma/*pathology/radiotherapy/surgery, Treatment Failure, Treatment Outcome.



76. E. Louis, F. Keime-Guibert, J. Y. Delattre, and M. Sanson. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri. Neurology, 60(1):151, 2003. Note: Case ReportsJournal ArticleUnited States. [WWW] Keyword(s): Adult, Antineoplastic Combined Chemotherapy Protocols/administration &, dosage/*therapeutic use, Biopsy, Brain Neoplasms/*diagnosis/*drug therapy, Corpus Callosum/pathology, Frontal Lobe/pathology, Humans, Lomustine/administration & dosage, Magnetic Resonance Imaging, Male, Neoplasms, Neuroepithelial/complications/*diagnosis/*drug therapy, Oligodendroglia/*pathology, Parietal Lobe/pathology, Procarbazine/administration & dosage, Remission Induction, Seizures/etiology, Tomography, X-Ray Computed, Treatment Outcome, Vincristine/administration & dosage.



77. E. Louis, N. Martin-Duverneuil, A. F. Carpentier, J. M. Mayer, and J. Y. Delattre. [Radiation-induced aneurysm of the cavernous internal carotid artery]. Rev Neurol (Paris), 159(3):319-22, 2003. Note: Case ReportsEnglish AbstractJournal ArticleFrance. [WWW] Keyword(s): Carotid Artery, Internal/pathology/*physiopathology/radiography, Cerebral Angiography, Functional Laterality/*physiology, Hodgkin Disease/radiotherapy, Humans, Intracranial Aneurysm/*diagnosis/*physiopathology, Magnetic Resonance Imaging, Male, Middle Aged, Radiotherapy/*adverse effects, Tomography, X-Ray Computed.



78. E. Mandonnet, J. Y. Delattre, M. L. Tanguy, K. R. Swanson, A. F. Carpentier, H. Duffau, P. Cornu, R. Van Effenterre, E. C. Jr Alvord, and L. Capelle. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol, 53(4):524-8, 2003. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Brain Neoplasms/*pathology, Cell Division, Female, Follow-Up Studies, Glioma/*pathology, Humans, Linear Models, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*pathology, Retrospective Studies.



79. G. Noel, J. Medioni, C. A. Valery, G. Boisserie, J. M. Simon, P. Cornu, D. Hasboun, D. Ledu, B. Tep, J. Y. Delattre, C. Marsault, F. Baillet, and J. J. Mazeron. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer, 41(3):333-43, 2003. Note: Clinical TrialJournal ArticleIreland. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*radiotherapy/*secondary/*surgery, Dose Fractionation, Female, Humans, Lung Neoplasms/*pathology, Male, Middle Aged, *Neoplasm Recurrence, Local, Prognosis, Radiosurgery/*methods, Survival Analysis, Treatment Outcome, Whole-Body Irradiation.



80. G. Noel, S. Noel, L. Feuvret, C. A. Valery, P. Cornu, G. Boisserie, D. Hasboun, B. Tep, J. Y. Delattre, F. Baillet, and J. J. Mazeron. [Stereotaxic irradiation of brain metastasis in elderly patients]. Bull Cancer, 90(10):896-904, 2003. Note: English AbstractJournal ArticleFrance. [WWW] Keyword(s): Aged, Aged, 80 and over, Brain Neoplasms/mortality/*secondary/*surgery, Confidence Intervals, Female, Follow-Up Studies, Humans, Male, Neoplasm Recurrence, Local, *Radiosurgery/adverse effects, Radiotherapy Dosage.



81. G. Noel, J. M. Simon, C. A. Valery, P. Cornu, G. Boisserie, D. Hasboun, D. Ledu, B. Tep, J. Y. Delattre, C. Marsault, F. Baillet, and J. J. Mazeron. Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol, 68(1):15-21, 2003. Note: Journal ArticleIrelandjournal of the European Society for Therapeutic Radiology and Oncology. [WWW] Keyword(s): Adenocarcinoma/pathology/*secondary/*surgery, Adult, Aged, Brain Neoplasms/pathology/*secondary/*surgery, Cranial Irradiation, Disease-Free Survival, Dose-Response Relationship, Radiation, Female, Humans, Male, Middle Aged, Radiosurgery/*methods.



82. S. Oudard, A. Carpentier, E. Banu, F. Fauchon, D. Celerier, M. F. Poupon, B. Dutrillaux, J. M. Andrieu, and J. Y. Delattre. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol, 63(1):81-6, 2003. Note: Clinical TrialClinical Trial, Phase IIJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Antineoplastic Combined Chemotherapy Protocols/adverse, effects/*therapeutic use, Brain Neoplasms/*drug therapy/pathology, Diazepam/administration & dosage, Female, Glioblastoma/*drug therapy/pathology, Humans, Indazoles/administration & dosage, Male, Middle Aged, Neoplasm Recurrence, Local/*drug therapy/pathology, Prognosis, Survival Rate.



83. I. Rojas-Marcos, D. Calvet, P. Janoray, and J. Y. Delattre. Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Neurology, 61(7):1019-20, 2003. Note: Case ReportsJournal ArticleUnited States. [WWW] Keyword(s): Adrenal Cortex Hormones/administration & dosage, Adult, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Brain/pathology/radiography, Brain Neoplasms/pathology/surgery/*therapy, Carboplatin/administration & dosage, Carmustine/administration & dosage/adverse effects, Dacarbazine/administration & dosage/*analogs & derivatives, Disease Progression, Dose Fractionation, Ependymoma/pathology/surgery/*therapy, Gadolinium/diagnostic use, Headache/etiology, Humans, Isotretinoin/administration & dosage, Magnetic Resonance Imaging, Male, Neoplasm Recurrence, Local, Remission Induction, Tamoxifen/administration & dosage, Tomography, X-Ray Computed, Treatment Outcome.



84. I. Rojas-Marcos, A. Rousseau, F. Keime-Guibert, R. Rene, S. Cartalat-Carel, J. Y. Delattre, and F. Graus. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine (Baltimore), 82(3):216-23, 2003. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Aged, Antibodies, Neoplasm/immunology, Antigens, Neoplasm/immunology, Breast Neoplasms/*complications, Female, Genital Neoplasms, Female/*complications, Humans, Middle Aged, Paraneoplastic Polyneuropathy/*complications/immunology, Retrospective Studies.



85. J. M. Simon, G. Noel, J. Chiras, K. Hoang-Xuan, J. Y. Delattre, F. Baillet, and J. J. Mazeron. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme. Radiother Oncol, 67(1):45-51, 2003. Note: Clinical TrialClinical Trial, Phase IIJournal ArticleResearch Support, Non-U.S. Gov'tIrelandjournal of the European Society for Therapeutic Radiology and Oncology. [WWW] Keyword(s): Adult, Aged, Biopsy, Brain/pathology, Brain Neoplasms/*drug therapy/pathology/*radiotherapy, Carbon Dioxide/*therapeutic use, Chi-Square Distribution, Combined Modality Therapy, Computer Graphics, Drug Therapy, Combination, Female, Glioblastoma/*drug therapy/pathology/*radiotherapy, Humans, Male, Middle Aged, Niacinamide/adverse effects/*therapeutic use, Oxygen/*therapeutic use, Proportional Hazards Models, Radiation-Sensitizing Agents/adverse effects/*therapeutic use, Retrospective Studies, Statistics, Nonparametric, Survival Analysis.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html